Otis Brawley

The Scientist Date: September 1, 1997 "THE SCIENTIST helps me stay informed. No other journal writes so comprehensively about science and science policy." OTIS BRAWLEY, Director Office of Special Populations, National Cancer Institute Otis Brawley was given a job last June to help plan and guide the National Cancer Institute's (NCI's) agenda and ensure that the questions asked by NCI-sponsored scientists are pertinent to all Americans and that questions pertinent to women, the elderly, minorit


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The Scientist

Date: September 1, 1997

OTIS BRAWLEY, Director
Office of Special Populations,
National Cancer Institute

Otis Brawley was given a job last June to help plan and guide the National Cancer Institute's (NCI's) agenda and ensure that the questions asked by NCI-sponsored scientists are pertinent to all Americans and that questions pertinent to women, the elderly, minorities, and cancer survivors are addressed.

In working with mentors in medical school, Brawley learned that oncology is not a depressing specialty; it is still a relatively young specialty with many opportunities. He is one of the United States' few black medical oncologists who has written and run clinical trials. Since 1991, he has been involved with a prostate prevention trial involving more than 18,000 people. One of his goals is to increase public understanding of the advantages of clinical trials.

Of THE SCIENTIST, Brawley says: "THE SCIENTIST helps me stay informed. No ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours